Impact Factor
3.78
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.15
953 total citations
h5-index
36
h5 depth signal
Cited share
84.6%
204 of 241
Total citations
953
Citation footprint
Metric signal
3.37
External metric anchor
Self-citation
1.5%
14 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
612
China
282
Germany
76
Japan
66
Italy
61
Citing Fields of Research
Digestive Disorders
528
Inflammatory Bowel Diseases & Infections
265
Liver Diseases
238
Liver & Colon Cancer
235
Hepatitis
173
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,457
Articles tracked across the journal lifetime
Indexed publication set
241
204 cited publications
Last 12 months
181
15.1 publications/month
Open access share
93.4%
169 OA publications in the last year
Leading citing country
United States
612 citing publications
Leading citing field
Digestive Disorders
528 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v9n1, Jan. 2018-
v3, 2012-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Liver Diseases
Inflammatory Bowel Diseases & Infections
Liver & Colon Cancer
Issuing & Sponsoring Bodies
Contributor
American College of Gastroenterology
Broad Categories
Gastroenterology
Digestive Disorders
Inflammatory Bowel Diseases & Infections
Liver & Colon Cancer
Liver Diseases
MeSH Descriptors
Gastroenterology
Gastrointestinal Diseases
Liver Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.14309/ctg.0000000000001121
Open DOI
Non-invasive fibrosis tests in Wilson Disease: Insights from the international Wilson Disease Registry and Barcelona Cohort.
Introduction: Non-invasive tests (NITs) accurately detect fibrosis and may reduce the need for liver biopsy (LB). Detection of advanced fibrosis (≥F3) is clinically important for prognosis, but few studies have explored the use of NITs i...
02
DOI 10.14309/ctg.0000000000001120
Open DOI
Immunoglobulin G and liver stiffness in autoimmune hepatitis: Timing matters more than biochemical correction
Objectives: Transient elastography may overestimate fibrosis in autoimmune hepatitis (AIH) because hepatic inflammation independently increases liver stiffness measurement (LSM). We aimed to determine which inflammation markers confound ...
03
DOI 10.14309/ctg.0000000000001119
Open DOI
Long-term Benefits of Mirikizumab on Patient-Reported Outcomes in Individuals with Crohn's Disease: 2-Year Results from the VIVID-2 Extension Study
Background: Mirikizumab, an anti-IL-23p19 monoclonal antibody, has demonstrated clinical efficacy in Crohn’s disease (CD), improving symptoms and quality of life (QoL) over one year in the VIVID-1 trial. This analysis from the VIVID-2 op...
04
DOI 10.14309/ctg.0000000000001118
Open DOI
Association between Crohn’s disease and pulmonary nodule patterns: an inverse probability-weighted analysis of real-world data
Background: Crohn’s disease (CD) is a systemic inflammatory disorder with potential pulmonary involvement; however, its association with pulmonary nodules and how disease phenotype, medication, and inflammation affect nodule characterist...
05
DOI 10.14309/ctg.0000000000001117
Open DOI
Preventable Visits to the Emergency Department in Patients with Cirrhosis
Background/Aims: Emergency department (ED) utilization is a major driver of healthcare costs in cirrhosis, yet the burden of preventable ED visits (EDVs) is understudied. We aimed to estimate the prevalence of potentially preventable EDV...
06
DOI 10.14309/ctg.0000000000001116
Open DOI
US Healthcare Professionals’ Management of MASH and Knowledge of GLP-1, GIP, and Glucagon Receptor Agonists
INTRODUCTION: Various combinations of agonists of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) are in clinical trials for the treatment of metab...
07
DOI 10.14309/ctg.0000000000001109
Open DOI
An Artificial Intelligence-Based Blood Test using protein and miRNA biomarkers for Colorectal Cancer Screening
INTRODUCTION: Colorectal cancer (CRC) is the third most diagnosed cancer worldwide. Only invasive screening methods have been shown to be effective in reducing CRC incidence through the detection of advanced adenomas (AA). This work aime...
08
DOI 10.14309/ctg.0000000000001112
Open DOI
Response to Khan et al
09
DOI 10.14309/ctg.0000000000001111
Open DOI
Optimal Corticosteroid Use in Patients With Severe Alcohol-Associated Hepatitis: A Systematic Review and Meta-Analysis
Background: The Lille score is an established tool to guide corticosteroid (CS) response and treatment in severe alcohol-associated hepatitis (AH), MELD score >20. However, its use in clinical trials has remained inconsistent. We perform...
10
Bibliographical & Catalog Notes
Official online journal of the American College of Gastroenterology (ACG).